RT Journal Article
SR Electronic
T1 Pandemic modelling for regions implementing an elimination strategy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.18.22277695
DO 10.1101/2022.07.18.22277695
A1 Hurford, Amy
A1 Martignoni, Maria M.
A1 Loredo-Osti, J.C.
A1 Anokye, Francis
A1 Arino, Julien
A1 Husain, Bilal Saleh
A1 Gaas, Brian
A1 Watmough, James
YR 2022
UL http://medrxiv.org/content/early/2022/11/15/2022.07.18.22277695.abstract
AB During the COVID-19 pandemic, some countries, such as Australia, China, Iceland, New Zealand, Thailand, and Vietnam successfully implemented an elimination strategy, enacting strict border control and periods of lockdowns to end community transmission. Atlantic Canada and Canada’s territories implemented similar policies, and reported long periods with no community cases. In Newfoundland and Labrador (NL), Nova Scotia, and Prince Edward Island a median of 80% or more of daily reported cases were travel-related from July 1, 2020 to May 31, 2021. With increasing vaccination coverage, it may be appropriate to exit an elimination strategy, but most existing epidemiological frameworks are applicable only to situations where most cases occur in the community, and are not appropriate for regions that have implemented an elimination strategy. To inform the pandemic response in regions that are implementing an elimination strategy, we extend importation modelling to consider post-arrival travel restrictions, and pharmaceutical and non-pharmaceutical interventions in the local community. We find that shortly after the Omicron variant had begun spreading in Canada, the expected daily number of spillovers, infections spread to NL community members from travelers and their close contacts, was higher than any time previously in the pandemic. By December 24, 2021, the expected number of spillovers was 44% higher than the previous high, which occurred in late July 2021 shortly after travel restrictions were first relaxed. We develop a method to assess the characteristics of potential future community outbreaks in regions that are implementing an elimination strategy. We apply this method to predict the effect of variant and vaccination coverage on the size of hypothetical community outbreaks in Mount Pearl, a suburb of the St. John’s metropolitan area in NL. Our methodology can be used to evaluate alternative plans to relax public health restrictions when vaccine coverage is high in regions that have implemented an elimination strategy. This manuscript was submitted as part of a theme issue on “Modelling COVID-19 and Preparedness for Future Pandemics”.Competing Interest StatementAH, MM, and JL-O were members of the Newfoundland and Labrador Predictive Analytics Modelling team and AH received funding from the Newfoundland and Labrador Department of Health and Community Services. Some data was provided by the Newfoundland and Labrador Center for Health Information. This work was not influenced by representatives of the Government of Newfoundland and Labrador.Funding StatementThis study was funded by the Emerging Infectious Disease Modelling Initiative Consortium (Canadian Network for Modelling Infectious Disease, Mathematics for Public Health, and the One Health Modelling Network for Emerging Infections). AH and MM received a grant from the Department of Health and Community Services, Newfoundland and Labrador.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health Research Ethics Board of Newfoundland and Labrador gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll publicly available data used in this study are available at https://github.com/ahurford/pandemic-COVID-zero, but until the work completes peer-review please request these data and code by emailing ahurford{at}mun.ca https://github.com/ahurford/pandemic-COVID-zero